Cadrenal Therapeutics, Inc. CVKD
1.02 USD -0.04 (-3.77%)
Nov 5, 2026, 11:15 AM EST
1.00 Day range 1.07
0.816 52-week range 13.11
- YTD
- -84.96%
- 1 year
- -92.00%
Analyst view
Price target (mean) 35.67 +3396.7% upside
Now 1.02
- Target (low)
- 30.00
- Target (mean)
- 35.67
- Target (high)
- 45.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.87 | -2.03 – -1.70 | -1.88 | +0.5% | 0 | 0.0% | 2 |
| Next quarter | -2.15 | -2.15 – -2.15 | -1.50 | -43.3% | 0 | 0.0% | 1 |
| Current year | -7.80 | -8.02 – -7.57 | -8.23 | +5.3% | 0 | 0.0% | 2 |
| Next year | -4.27 | -5.76 – -2.78 | -7.80 | +45.2% | 0 | 0.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 11, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jun 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 9, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 18, 2023 | Noble Capital Markets | Initiated | — | Outperform |
| Nov 20, 2023 | HC Wainwright & Co. | Initiated | — | Buy |